Tarsus Pharmaceuticals, Inc.(TARS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TARS Tarsus Pharmaceuticals, Inc.

Closed 07-10 16:00:00 EDT

58.14

-6.00

-9.35%

盘后57.32

-0.82-1.41%

16:35 EDT

High63.84	Low57.51	Vol2.37M
Open63.74	D1 Closing64.14	Amplitude9.87%
Mkt Cap2.50B	Tradable Cap1.87B	Total Shares43.02M
T/O139.85M	T/O Rate7.37%	Tradable Shares32.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TARS","market":"US","secType":"STK","nameCN":"Tarsus Pharmaceuticals, Inc.","latestPrice":58.14,"timestamp":1783713600000,"preClose":64.14,"halted":0,"volume":2367158,"hourTrading":{"tag":"盘后","latestPrice":57.3224,"preClose":58.14,"latestTime":"16:35 EDT","volume":3462,"amount":200473.52,"timestamp":1783715727768,"change":-0.8176,"changeRate":-0.014063,"amplitude":0.014063},"delay":0,"changeRate":-0.09354536950420954,"floatShares":32112100,"shares":43023959,"eps":-1.130674,"marketStatus":"Closed","change":-6,"latestTime":"07-10 16:00:00 EDT","open":63.74,"high":63.84,"low":57.51,"amount":139853486.578606,"amplitude":0.09869,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.130674,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783929600000},"marketStatusCode":5,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":64.14,"preHourTrading":{"tag":"盘前","latestPrice":63.14,"preClose":64.14,"latestTime":"09:29 EDT","volume":3410,"amount":218459.2289,"timestamp":1783690196889,"change":-1,"changeRate":-0.015591,"amplitude":0.039133},"postHourTrading":{"tag":"盘后","latestPrice":57.3224,"preClose":58.14,"latestTime":"16:35 EDT","volume":3462,"amount":200473.52,"timestamp":1783715727768,"change":-0.8176,"changeRate":-0.014063,"amplitude":0.014063},"volumeRatio":1.404179,"impliedVol":0.8117,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/TARS/tweets","defaultTab":"tweets","newsList":[{"id":"2650925591","title":"Tarsus Pharmaceuticals Price Target Maintained with a $88.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2650925591","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650925591?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:35","pubTimestamp":1783593300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TARS/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 06:35 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923855","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923855?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:50","pubTimestamp":1783590627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Tarsus Pharmaceutica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","HIMS","HIMY","TARS","HIMZ","THNR","HMYY","BK4196","HIYY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650916219","title":"Tarsus Publishes Investor Presentation on Irenix Acquisition, Irx-101 Ocular Antiseptic Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2650916219","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650916219?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:59","pubTimestamp":1783544360,"startTime":"0","endTime":"0","summary":"Tarsus publishes investor presentation on iRenix acquisition, IRX-101 ocular antiseptic programTarsus unveiled its acquisition of iRenix Medical, adding IRX-101 to expand into the retina market.Deal t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL1TY29M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915973","title":"Tarsus Pharmaceuticals Buys Irenix Medical in Deal with USD 75 Million Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915973","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915973?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:07","pubTimestamp":1783541244,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals buys iRenix Medical in deal with USD 75 million upfront paymentTarsus Pharmaceuticals agreed to acquire privately held iRenix Medical, adding late-stage ocular antiseptic candid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL3B4lG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BN0W2W23.USD","TARS","IE00BKPKM429.USD","BCDF","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4007","LU2210150020.SGD","BK4585","BK4588","IE00BN0W2V16.EUR","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915942","title":"Tarsus Pharmaceuticals - Upfront Consideration for Deal Totals $75 Mln: $37.5 Mln Cash, $37.5 Mln Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915942?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA3YSG8D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915150","title":"Tarsus Pharmaceuticals - to Begin Phase 3 Irx-101 Study in H1 2027, Results Expected 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915150?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA3YSG8D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650391599","title":"Tarsus Advances Eye Care Leadership Strategy with Acquisition of Irenix Medical and Late-stage Asset Irx-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2650391599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650391599?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA3YSG8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650159459","title":"Tarsus Pharmaceuticals - Potential Milestone Payments up to $490 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2650159459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650159459?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA3YSG8D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650321916","title":"Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2650321916","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650321916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:05","pubTimestamp":1783541100,"startTime":"0","endTime":"0","summary":"IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard of care Positive Phase 2b/3 data and an FDA-aligned Phase 3 program provide","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324437/0/en/Tarsus-Advances-Eye-Care-Leadership-Strategy-with-Acquisition-of-iRenix-Medical-and-Late-Stage-Asset-IRX-101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649988963","title":"Culper Research Says We are Short Tarsus Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2649988963","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649988963?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:34","pubTimestamp":1783413277,"startTime":"0","endTime":"0","summary":"July 1 (Reuters) - :*CULPER RESEARCH - WE ARE SHORT TARSUS PHARMACEUTICALS((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 01-JUL-202617:04:19 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSD88KxLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649623793","title":"Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649623793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649623793?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:40","pubTimestamp":1783334416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eton-pharmaceuticals-eton-tarsus-pharmaceuticals-tars-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eton-pharmaceuticals-eton-tarsus-pharmaceuticals-tars-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","HCSG","XBI","TARS","ARWR","BK4007","ETON","BK4585","LU0029874061.USD","BK4139","BK4588","BK4137","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648050673","title":"Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648050673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648050673?lang=en_us&edition=fundamental","pubTime":"2026-07-02 18:00","pubTimestamp":1782986449,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BrightSpring Health Services, Inc. (BTSG) and Tarsus...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brightspring-health-services-inc-btsg-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brightspring-health-services-inc-btsg-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4007","XBI","XLV","LU0029874061.USD","BK4588","TARS","BTSG","LU2468319806.SGD","HCSG","LU2089984988.USD","LABU","BK4137","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525890","title":"Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525890","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648525890?lang=en_us&edition=fundamental","pubTime":"2026-07-02 02:13","pubTimestamp":1782929580,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals Inc (NASDAQ:TARS) shares are falling Wednesday. Short-seller Culper Research published a report Wednesday alleging the company's sole commercial product relies on an illegal Medicare copay scheme. Here's what you should know.","market":"hk","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/07/01/Creative-Glowing-Candlestick-Forex-Chart.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/07/01/Creative-Glowing-Candlestick-Forex-Chart.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/07/60228364/tarsus-pharmaceuticals-stock-drops-as-short-seller-alleges-illegal-copay-scheme","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/07/60228364/tarsus-pharmaceuticals-stock-drops-as-short-seller-alleges-illegal-copay-scheme","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501528","title":"Tarsus Pharmaceuticals Faces Medicare Copay Allegations From Culper Research; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501528","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501528?lang=en_us&edition=fundamental","pubTime":"2026-07-02 02:11","pubTimestamp":1782929489,"startTime":"0","endTime":"0","summary":"Short seller Culper Research said Wednesday it has taken a short position in Tarsus Pharmaceuticals , alleging the commercialization of Xdemvy relies on a Medicare copay assistance structure that \"raises serious Anti-Kickback Statute concerns.\"Culper alleged Tarsus funds a charitable foundation that subsidizes Medicare copays for Xdemvy patients and said the arrangement bears \"many of the attributes of the arrangements that have been prosecuted\" by the US Department of Justice.The short seller also argued Tarsus' addressable market is \"a fraction  of the Company's claims\" and projected Xdemvy revenue would \"peak below $800 million at best,\" compared with the company's long-term target of more than $2 billion.Culper further argued that analysts underestimate Tarsus' patient assistance costs and said the company's profitability \"will never materialize\" because those expenses are higher than Wall Street expects.Tarsus did not immediately respond to MT Newswires' request for comment.Shares","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648054012","title":"Tarsus Falls After Short Seller Flags Concerns over Eye Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2648054012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648054012?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:27","pubTimestamp":1782926864,"startTime":"0","endTime":"0","summary":"BUZZ-Tarsus falls after short seller flags concerns over eye drug** Shares of drugmaker Tarsus PharmaceuticalsTARS.Ofall 7.2% to $58.39** Short seller Culper Research says it is short TARS, alleging g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL4N4331GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540615","title":"Culper Research announces Tarsus Pharmaceuticals short position","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540615?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:05","pubTimestamp":1782925520,"startTime":"0","endTime":"0","summary":"Culper Research said on X: “NEW: We are short Tarsus Pharmaceuticals (TARS) $TARS, maker of XDEMVY, a $2,000 eyedrop for demodex blepharitis. We th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/culper-research-announces-tarsus-pharmaceuticals-short-position-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/culper-research-announces-tarsus-pharmaceuticals-short-position-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SOCL","TARS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648547081","title":"Culper Research - We are Short Tarsus Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2648547081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648547081?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:02","pubTimestamp":1782925322,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN43313R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647027943","title":"Tarsus Pharmaceuticals Stockholders Approve Governance and Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2647027943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647027943?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:52","pubTimestamp":1782766361,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals ( ($TARS) ) just unveiled an update. On June 25, 2026, Tarsus Pharmaceuticals held its Annual Meeting of Stockholders, with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tarsus-pharmaceuticals-stockholders-approve-governance-and-oversight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tarsus-pharmaceuticals-stockholders-approve-governance-and-oversight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304706","title":"Tarsus Pharmaceuticals Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304706?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:20","pubTimestamp":1782764434,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals holds annual shareholder meetingTarsus Pharmaceuticals held its annual shareholder meeting on June 25, 2026.Shareholders elected four Class III directors to serve until the 2029","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL1hpYGm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645077404","title":"Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2645077404","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645077404?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:10","pubTimestamp":1782159044,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals CEO, President, board chair Bobak R. Azamian sold 10,000 common shares on June 17.Sales were priced at USD 61.24 to USD 61.81 per share.Holdings in the reported trust fell to 847,991 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLbBTpWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tarsusrx.com","stockEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":0.0421},{"period":"3month","weight":-0.116},{"period":"6month","weight":-0.1656},{"period":"1year","weight":0.5534},{"period":"ytd","weight":-0.2167}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.002743},{"month":2,"riseRate":0.333333,"avgChangeRate":0.037237},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.051747},{"month":4,"riseRate":0.5,"avgChangeRate":0.00177},{"month":5,"riseRate":0.5,"avgChangeRate":-0.038644},{"month":6,"riseRate":0.5,"avgChangeRate":-0.027034},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017226},{"month":8,"riseRate":0.8,"avgChangeRate":0.123751},{"month":9,"riseRate":0.8,"avgChangeRate":0.033781},{"month":10,"riseRate":0.8,"avgChangeRate":0.135195},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092511},{"month":12,"riseRate":0.666667,"avgChangeRate":0.122111}],"exchange":"NASDAQ","name":"Tarsus Pharmaceuticals, Inc.","nameEN":"Tarsus Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tarsus Pharmaceuticals, Inc.(TARS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tarsus Pharmaceuticals, Inc.(TARS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tarsus Pharmaceuticals, Inc.,TARS,Tarsus Pharmaceuticals, Inc.股票,Tarsus Pharmaceuticals, Inc.股票老虎,Tarsus Pharmaceuticals, Inc.股票老虎国际,Tarsus Pharmaceuticals, Inc.行情,Tarsus Pharmaceuticals, Inc.股票行情,Tarsus Pharmaceuticals, Inc.股价,Tarsus Pharmaceuticals, Inc.股市,Tarsus Pharmaceuticals, Inc.股票价格,Tarsus Pharmaceuticals, Inc.股票交易,Tarsus Pharmaceuticals, Inc.股票购买,Tarsus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tarsus Pharmaceuticals, Inc.(TARS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tarsus Pharmaceuticals, Inc.(TARS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}